Target intelligence / Profile preview

RNA, U6 small nuclear 1219, pseudogene (RNU6-1219P)

Target
RNU6-1219P
Molecular classification
Other (Pseudogene), Small nuclear RNA (snRNA, pseudogene copy)
01

Overview

RNA, U6 small nuclear 1219, pseudogene (RNU6-1219P) is a non-protein coding pseudogene related to U6 small nuclear RNA (snRNA), which itself is a highly conserved component of the spliceosome that catalyzes pre-mRNA splicing in eukaryotes[1][3]. RNU6-1219P, as a pseudogene, is not known to produce a functional transcript or protein, nor to participate directly in spliceosomal activity or cellular regulation. While U6 snRNA and its active genes are essential for viability and gene expression, pseudogenes like RNU6-1219P typically do not encode functional RNAs and lack therapeutic or biomarker utility[1][3][5]. There is no evidence in the current literature of RNU6-1219P functioning as a drug target, disease marker, or regulatory RNA[5]. Note: While some pseudogenes participate in regulatory RNA processes (such as acting as competing endogenous RNAs)[4], this has not been shown for RNU6-1219P specifically. Key Guidance: - The name refers to a pseudogene, not to an active or therapeutic target. - There are thousands of such U6 snRNA-derived pseudogenes in the human genome, generally without functional or clinical significance[1][5].

Other names
RNU6-1219P
02

Biological functions

Other (No established biological function; see description)
03

Disease associations

Other (No established role; see description)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1219, pseudogene (RNU6-1219P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1219, pseudogene (RNU6-1219P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call